Username Password
S&P 500: 1,351.68 Change: +0.14%

CUBIST PHARMACEUTICALS INC (CBST)

Overview
Price 40.34
Price Change Today 0.00 (0.00%)
P&P rating Rating: 4
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $40.34
Daily Range $0.00 - $0.00
52-Week Range $21.39 - $42.39
Volume 0
chart
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN, the first antibiotic in a new class of antiinfectives called lipopeptides. The Cubist product pipeline includes our lipopeptide program and our natural products screening program. Cubist is headquartered in Lexington, MA.
Other Resources for CBST
zacks.com
Commentary
Zacks Blog: Cubicin Drives Cubist Pharma
January 20, 2012
Zacks Blog: Earnings Preview: Cubist Pharma
January 17, 2012
Zacks Blog: Optimer Buoyant on Difficid Sales
January 12, 2012
Zacks Blog: Cubist's Preliminary Sales Impress
January 11, 2012
Zacks Blog: Alnylam States Preclinical Data
December 30, 2011
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN, the first antibiotic in a new class of antiinfectives called lipopeptides. The Cubist product pipeline includes our lipopeptide program and our natural products screening program. Cubist is headquartered in Lexington, MA.
 
Brokerage Analyst Recommendations
14 Brokerage Firms Covering CBST
 
   
Strong Buy
9
Buy
1
Hold
4
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.64
 
CBST Ratings:BUY  SELL  HOLD
CBST Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

17 Buy
0 Sell
 
Top Buy Analysis
BUY: CBST Rating: 4
Company: CUBIST PHARMACEUTICALS INC.
Points: 53.89
Start Price: $21.97
Start Date: 09/12/2009 6:05 PM
Peterjr
Peterjr
P&P Score: 99.14
Recs:
Cubist Pharm Quarterly net revenue plus family is active in the company

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 07/17/09 Zantrio.com Stock Picks for July 17, 2009 0
Zacks_Analysts
0.00 01/20/12 Cubicin Drives Cubist Pharma - Analyst Blog 0
Zacks_Analysts
0.00 01/17/12 Earnings Preview: Cubist Pharma - Analyst Blog 0
Zacks_Analysts
0.00 01/12/12 Optimer Buoyant on Difficid Sales - Analyst Blog 0
Zacks_Analysts
0.00 01/11/12 Cubist's Preliminary Sales Impress - Analyst Blog 0
Zacks_Analysts
0.00 12/30/11 Alnylam States Preclinical Data - Analyst Blog 0
Zacks_Analysts
0.00 12/15/11 Pipeline Progress at Cubist Pharma - Analyst Blog 0
Zacks_Analysts
0.00 12/14/11 Optimer's Dificlir Cleared in EU - Analyst Blog 0
Zacks_Analysts
0.00 12/13/11 Cubist Pharma Buys Adolor - Analyst Blog 0
Zacks_Analysts
0.00 12/07/11 Still Bullish on Alnylam - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   6   7  >>
Commentary
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $36.78
Points: +3.69
Created: 11/08/2011
sell at 40

Comments: 0 | Comment

Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $21.54
Points: +70.24
Created: 05/11/2010
It's about time something happened with this one.

Comments: 0 | Comment

Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $21.97
Points: +53.89
Created: 09/12/2009
Cubist Pharm Quarterly net revenue plus family is active in the company

Comments: 0 | Comment

Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $22.70
Points: +66.58
Created: 04/24/2010

Comments: 0 | Comment

dmb dmb
Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $17.66
Points: +79.76
Created: 10/09/2008

Comments: 0 | Comment

Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $17.66
Points: +91.08
Created: 10/08/2008

Comments: 0 | Comment

Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $22.01
Points: +91.11
Created: 01/01/2008

Comments: 0 | Comment

jay jay
Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $23.18
Points: +81.86
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $21.54
Points: +95.11
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CUBIST PHARMACEUTICALS INC. (CBST) Rating: 4
Start Price: $22.41
Points: +87.84
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
hensonguess 97.69 BUY Week or Less 11/08/2011 $36.78 $40.32
(-1.32%)
+9.62% +5.94% +3.69 view
ogginatsog 23.26 BUY Three to Six Months 05/11/2010 $21.54 $40.32
(-1.32%)
+87.19% +16.95% +70.24 view
dmb 0.25 BUY Six Months to a Year 04/24/2010 $22.70 $40.32
(-1.32%)
+77.62% +11.04% +66.58
Peterjr 99.14 BUY Six Months to a Year 09/12/2009 $21.97 $40.32
(-1.32%)
+83.52% +29.63% +53.89 view
Enthusiastic 53.45 BUY One to Three Months 10/09/2008 $17.66 $40.32
(-1.32%)
+128.31% +48.55% +79.76
OpeningBell 43.35 BUY Three to Six Months 10/08/2008 $17.66 $40.32
(-1.32%)
+128.31% +37.23% +91.08
jay 78.97 BUY Six Months to a Year 01/01/2008 $22.01 $40.32
(-1.32%)
+83.19% -7.92% +91.11
Scott2006 46.60 BUY Six Months to a Year 01/01/2008 $23.18 $40.32
(-1.32%)
+73.94% -7.92% +81.86
JONEBOY 74.50 BUY Six Months to a Year 01/01/2008 $21.54 $40.32
(-1.32%)
+87.19% -7.92% +95.11
wolf 53.45 BUY Six Months to a Year 01/01/2008 $22.41 $40.32
(-1.32%)
+79.92% -7.92% +87.84
Pages: [ 1 ]  2  >>
Sponsored Links